Dear NNPDF Families and Friends,
The NNPDF Central Office is pleased to provide our Niemann-Pick type C family membership community with a summary from the April 16th Vtesse sponsored webinar for those of you who could not be in attendance. Please find the PDF document via this link: http://www.nnpdf.org/Vtesse.html#Podcast
The Vtesse webinar addressed the progress and updates tied to plans for the VTS-270 (cyclodextrin) Phase II & III clinical trials for Niemann-Pick Disease, Type C (NPC). To see an agenda of the topics discussed during the call ~ please follow this link: April 16th Vtesse sponsored webinar
In addition, we are including a podcast with Ben Machielse, CEO of Vtesse, Inc as he discusses:
- What is Niemann-Pick Disease type C.
- The role that NPC parents & patients have played in getting the research moving forward.
- How NIH & NCATS paved the way for the Cyclodextrin clinical trial.
- Vtesse, Inc, Cydan and how they became involved with Cyclodextrin.
Visit the Vtesse page on the NNPDF web site for the PDF webinar summary and Podcast: http://www.nnpdf.org/Vtesse.html#Podcast